Literature DB >> 23134681

Shaking the family tree: identification of novel and biologically active alternatively spliced isoforms across the KLF family of transcription factors.

Olga Camacho-Vanegas1, Jacob Till, Irene Miranda-Lorenzo, Berrin Ozturk, Sandra Catalina Camacho, John A Martignetti.   

Abstract

Alternative splicing represents a unique post-transcriptional mechanism that increases the complexity of the eukaryotic proteome-generating protein isoforms whose functions can be novel, diverse, and/or even antagonistic when compared to its full-length transcript. The KLF family of genes consists of ≥17 members, which are involved in the regulation of numerous critical cellular processes, including differentiation, cell proliferation, growth-related signal transduction, angiogenesis, and apoptosis. Using a strategy based on RT-PCR, selective cloning, and promoter-based assays of cancer-relevant genes, we identify and characterize the existence of multiple biologically active KLF splice forms across the entire family of proteins. We demonstrate biological function for a number of these isoforms. Furthermore, we highlight a possible functional interaction between full-length KLF4 and one of its splice variants in up-regulating cellular proliferation. Taken together, this report identifies for the first time a more complete view of the genomic and proteomic breadth and complexity of the KLF transcription factor family, revealing the existence of highly expressed and biologically active isoforms previously uncharacterized. In essence, knowing that these KLF isoforms exist provides the first step toward understanding the roles of these genes in human health and disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134681     DOI: 10.1096/fj.12-220319

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

Review 1.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 2.  Krüppel-like factor 4 (KLF4): What we currently know.

Authors:  Amr M Ghaleb; Vincent W Yang
Journal:  Gene       Date:  2017-02-22       Impact factor: 3.688

Review 3.  The Krüppel-like factors in female reproductive system pathologies.

Authors:  Rosalia C M Simmen; Melissa E Heard; Angela M Simmen; Maria Theresa M Montales; Meera Marji; Samantha Scanlon; John Mark P Pabona
Journal:  J Mol Endocrinol       Date:  2015-02-05       Impact factor: 5.098

Review 4.  Role of Krüppel-like factors in cancer stem cells.

Authors:  Yueling Zhang; Jin Hao; Yingcheng Zheng; Dian Jing; Yu Shen; Jun Wang; Zhihe Zhao
Journal:  J Physiol Biochem       Date:  2015-01-24       Impact factor: 4.158

5.  Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.

Authors:  Valerie A Morris; Carrie L Cummings; Brendan Korb; Sean Boaglio; Vivian G Oehler
Journal:  Mol Cell Biol       Date:  2015-12-07       Impact factor: 4.272

6.  The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.

Authors:  Wenwen Li; Man Liu; Ying Su; Xinying Zhou; Yao Liu; Xinyan Zhang
Journal:  Oncotarget       Date:  2015-12-29

7.  KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.

Authors:  M Riverso; V Montagnani; B Stecca
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

8.  Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.

Authors:  Chuangui Chen; Zhao Ma; Hongdian Zhang; Xiaoqiong Liu; Zhentao Yu
Journal:  Med Sci Monit       Date:  2017-07-11

9.  KLF4α stimulates breast cancer cell proliferation by acting as a KLF4 antagonist.

Authors:  Jacqueline Ferralli; Ruth Chiquet-Ehrismann; Martin Degen
Journal:  Oncotarget       Date:  2016-07-19

Review 10.  Prognostic significance of KLF4 in solid tumours: an updated meta-analysis.

Authors:  Xiaoya Luo; Yue Zhang; Ying Meng; Ming Ji; Yongjun Wang
Journal:  BMC Cancer       Date:  2022-02-17       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.